Kusajili – Clinical trials directory

Result of your search per specialist: Prof Frederic Rouillon

Woman and Man Max 99 years
Institut de Recherches Internationales Servier (France) Update Il y a 4 ans

A study to determine the maintenance of efficacy of agomelatine to prevent relapse in out-patients with major depressive disorder. A 8 to 10 weeks open period treatment with agomelatine followed by 24 weeks randomised double-blind period, placebo-controlled, parallel groups and 20 weeks of optional double-blind treatment period Not provided at time of registration and not expected to be available in the future

Country Australia, Finland, France, South Africa, United Kingdom
organs None
Specialty None

Closed trial

More information